JP2025513337A5 - - Google Patents
Info
- Publication number
- JP2025513337A5 JP2025513337A5 JP2024561787A JP2024561787A JP2025513337A5 JP 2025513337 A5 JP2025513337 A5 JP 2025513337A5 JP 2024561787 A JP2024561787 A JP 2024561787A JP 2024561787 A JP2024561787 A JP 2024561787A JP 2025513337 A5 JP2025513337 A5 JP 2025513337A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- individual
- blood pressure
- systolic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263332909P | 2022-04-20 | 2022-04-20 | |
| US63/332,909 | 2022-04-20 | ||
| PCT/US2023/018998 WO2023205183A1 (en) | 2022-04-20 | 2023-04-18 | Istaroxime-containing intravenous formulation for the treatment of pre-cardiogenic shock and cardiogenic shock |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513337A JP2025513337A (ja) | 2025-04-24 |
| JP2025513337A5 true JP2025513337A5 (enExample) | 2026-04-24 |
Family
ID=86331896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024561787A Pending JP2025513337A (ja) | 2022-04-20 | 2023-04-18 | 心原性ショック前および心原性ショックの処置のためのイスタロキシムを含む静脈内注入製剤 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4511040A1 (enExample) |
| JP (1) | JP2025513337A (enExample) |
| KR (1) | KR20250005343A (enExample) |
| CN (1) | CN119156218A (enExample) |
| AU (1) | AU2023256547A1 (enExample) |
| CA (1) | CA3248625A1 (enExample) |
| IL (1) | IL316164A (enExample) |
| MX (1) | MX2024012948A (enExample) |
| WO (1) | WO2023205183A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025128432A1 (en) * | 2023-12-11 | 2025-06-19 | Windtree Therapeutics, Inc. | Istaroxime and metabolite derivatives thereof for reducing the risk of acute myocardial arrhythmia |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1079807A (en) | 1912-09-25 | 1913-11-25 | Jonathan S Snyder | Coat-closure. |
| NL95803C (enExample) | 1953-12-31 | 1900-01-01 | ||
| US4534899A (en) | 1981-07-20 | 1985-08-13 | Lipid Specialties, Inc. | Synthetic phospholipid compounds |
| US5846743A (en) | 1995-02-22 | 1998-12-08 | Brigham And Women's Hospital, Inc. | Polyphoshoinositide binding peptides for intracellular drug delivery |
| US6007839A (en) | 1996-02-16 | 1999-12-28 | The Liposome Company, Inc. | Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes |
| US5874268A (en) | 1996-09-23 | 1999-02-23 | Duke University | Method of introducing exogenous compounds into cells by electroporation and apparatus for same |
| CN1261791A (zh) | 1997-07-02 | 2000-08-02 | Sdg有限公司 | 诊断或治疗用途的靶向脂质体构建物 |
| SE9704076D0 (sv) | 1997-11-06 | 1997-11-06 | Holdingbolaget Vid Goeteborgs | Method for permeabilisation of cell structures and use thereof |
| US6589503B1 (en) | 1998-06-20 | 2003-07-08 | Washington University | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| US20040151766A1 (en) | 2003-01-30 | 2004-08-05 | Monahan Sean D. | Protein and peptide delivery to mammalian cells in vitro |
| WO2005063156A1 (en) | 2003-12-22 | 2005-07-14 | Shear/Kershman Laboratories, Inc. | Oral peptide delivery system with improved bioavailability |
| KR20060123384A (ko) | 2003-12-24 | 2006-12-01 | 가부시키가이샤 엘티티 바이오파마 | 약물을 함유하는 나노 입자 및 그 제조 방법, 그리고 당해나노 입자로 이루어지는 비경구 투여용 제제 |
| US20070082042A1 (en) | 2004-08-06 | 2007-04-12 | Deok-Hoon Park | Multiple-layered liposome and preparation method thereof |
| EP1812074B1 (en) | 2004-10-18 | 2010-12-29 | Nitto Denko Corporation | Intracellular peptide delivery |
| JP5639338B2 (ja) | 2005-07-27 | 2014-12-10 | プロチバ バイオセラピューティクス インコーポレイティッド | リポソームの製造システムおよび製造方法 |
| CN103315968B (zh) | 2013-06-26 | 2015-04-01 | 中国生命药物治疗有限公司 | 一种注射用粉针剂及其制备方法 |
| CN112118846B (zh) | 2019-03-05 | 2024-04-16 | 风树疗法公司 | 治疗急性心力衰竭(ahf)用的含伊司他肟的静脉内制剂 |
-
2023
- 2023-04-18 CA CA3248625A patent/CA3248625A1/en active Pending
- 2023-04-18 KR KR1020247038640A patent/KR20250005343A/ko active Pending
- 2023-04-18 EP EP23723312.7A patent/EP4511040A1/en active Pending
- 2023-04-18 JP JP2024561787A patent/JP2025513337A/ja active Pending
- 2023-04-18 IL IL316164A patent/IL316164A/en unknown
- 2023-04-18 CN CN202380035206.5A patent/CN119156218A/zh active Pending
- 2023-04-18 WO PCT/US2023/018998 patent/WO2023205183A1/en not_active Ceased
- 2023-04-18 AU AU2023256547A patent/AU2023256547A1/en active Pending
-
2024
- 2024-10-21 MX MX2024012948A patent/MX2024012948A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20080032933A1 (en) | Type V Phosphodiesterase Inhibitors and Natriuretic Polypeptides | |
| Lairez et al. | Cardiovascular effects of low-dose spinal anaesthesia as a function of age: an observational study using echocardiography | |
| US20110002843A1 (en) | Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm | |
| JP7444432B2 (ja) | 心血管疾患を治療する方法 | |
| WO2024255256A1 (zh) | 丙酮酸脱氢酶激酶抑制剂在治疗射血分数保留型心力衰竭中的应用 | |
| Lang et al. | Pulmonary hypertension | |
| Aronow | Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons | |
| CN119156218A (zh) | 用于治疗心源性休克前期和心源性休克的含有istaroxime的静脉内制剂 | |
| Morton et al. | “Ventricular function curve” from a single diagnostic left ventriculogram: technique, results and value | |
| Sharma et al. | Symptomatic myocardial bridges in children: a case report with review of literature | |
| RU2748527C1 (ru) | Способ выявления ишемической болезни сердца (ИБС) и микрососудистой дисфункции у пациентов с подозрением на острый коронарный синдром | |
| Kamiya et al. | A case of marked diuresis by combined dopamine and atrial natriuretic peptide administration without renal injury in acute decompensated heart failure | |
| KR102178355B1 (ko) | 심장 질환 치료용 조성물 | |
| Bahl et al. | Takayasu's arteritis revisited | |
| Oleksiak et al. | Safety of regadenoson with theophylline reversal during dynamic computed tomography perfusion and magnetic resonance imaging in patients with coronary artery disease | |
| Claudio et al. | A focus on pharmacological management of catecholaminergic polymorphic ventricular tachycardia | |
| Imnadze et al. | Myocardial bridge complicated by acute myocardial infarction. | |
| Bansro et al. | A young adult with myocardial bridging: a case report | |
| CN116966176A (zh) | 脂肪酸结合蛋白4抑制剂在治疗射血分数保留型心力衰竭中的应用 | |
| Sungkar et al. | Late presentation of arrhythmogenic right ventricular cardiomyopathy: role of non invasive modalities for the diagnosis | |
| Shaer et al. | Sarcoid Heart Disease: A Case Report and Literature Review | |
| De Ycaza et al. | Unexplained Positional Hypoxemia in an Elderly Patient: A Case of Platypnea–Orthodeoxia Syndrome | |
| Varinder et al. | A Young Adult With Myocardial Bridging: A Case Report | |
| Günaydin et al. | Peripartum cardiomyopathy associated with triplet pregnancy | |
| YILDIRIM | CARDIOMYOPATHY CAUSED BY STRESS DUE TO FEAR OF UNDERGOING MAGNETIC RESONANCE IMAGING |